We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$228B
AUM Growth
-$15.4B
Cap. Flow
-$1.28B
Cap. Flow %
-0.56%
Top 10 Hldgs %
13.8%
Holding
11,885
New
1,175
Increased
4,825
Reduced
3,846
Closed
1,024

Sector Composition

Rank Sector Weight
1 Technology 10.88%
2 Financials 6.67%
3 Healthcare 6.52%
4 Consumer Discretionary 4.99%
5 Industrials 4.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRVA icon
4601
Privia Health
PRVA
$2.74B
$367K ﹤0.01%
10,789
-38,876
-78% -$1.44M
GIII icon
4602
G-III Apparel Group
GIII
$1.41B
$365K ﹤0.01%
24,382
+23,812
+4,178% +$486K
SGML icon
4603
Sigma Lithium
SGML
$1.34B
$365K ﹤0.01%
13,393
-4,458
-25% -$93.3K
SPWH icon
4604
Sportsman's Warehouse
SPWH
$46M
$365K ﹤0.01%
43,962
+39,548
+896% +$375K
RELX icon
4605
RELX
RELX
$60.1B
$364K ﹤0.01%
14,953
-6,256
-29% -$170K
CWCO icon
4606
Consolidated Water Co
CWCO
$509M
$363K ﹤0.01%
23,633
+13,731
+139% +$216K
URGN icon
4607
UroGen Pharma
URGN
$2.34B
$363K ﹤0.01%
43,589
+17,719
+68% +$147K
MSGR
4608
DELISTED
Direxion mRNA ETF
MSGR
$363K ﹤0.01%
26,810
+753
+3% +$11.3K
MAXN
4609
DELISTED
Maxeon Solar Technologies
MAXN
$362K ﹤0.01%
153
+2
+1% +$3.69K
NUGT icon
4610
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.25B
$362K ﹤0.01%
14,292
+13,434
+1,566% +$386K
PCT icon
4611
PureCycle Technologies
PCT
$1.5B
$362K ﹤0.01%
44,852
+28,924
+182% +$247K
PDN icon
4612
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$367M
$362K ﹤0.01%
14,129
-21,011
-60% -$611K
ALLT icon
4613
Allot
ALLT
$393M
$361K ﹤0.01%
92,239
-45,725
-33% -$217K
PFBC icon
4614
Preferred Bank
PFBC
$1.27B
$361K ﹤0.01%
5,526
+5,414
+4,834% +$378K
PFL
4615
PIMCO Income Strategy Fund
PFL
$390M
$361K ﹤0.01%
45,249
-5,690
-11% -$51.5K
VLU icon
4616
State Street SPDR S&P 1500 Value Tilt ETF
VLU
$778M
$361K ﹤0.01%
2,865
+2,815
+5,630% +$392K
FRLN
4617
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$361K ﹤0.01%
34,413
+777
+2% +$10.1K
GGB icon
4618
Gerdau
GGB
$9.38B
$359K ﹤0.01%
100,253
+773
+0.8% +$2.81K
SANA icon
4619
Sana Biotechnology
SANA
$1.12B
$359K ﹤0.01%
59,833
-167,166
-74% -$1.21M
TASK icon
4620
TaskUs
TASK
$606M
$359K ﹤0.01%
22,293
+2,588
+13% +$45.7K
VREX icon
4621
Varex Imaging
VREX
$781M
$359K ﹤0.01%
17,009
+294
+2% +$6.43K
BIOX icon
4622
Bioceres Crop Solutions
BIOX
$24.2M
$358K ﹤0.01%
27,493
+5,412
+25% +$66.4K
FFIC
4623
DELISTED
Flushing Financial
FFIC
$358K ﹤0.01%
18,480
+1,034
+6% +$22.1K
GAIN icon
4624
Gladstone Investment Corp
GAIN
$656M
$358K ﹤0.01%
29,620
-13,142
-31% -$189K
GFS icon
4625
GlobalFoundries
GFS
$28.9B
$358K ﹤0.01%
7,401
+3,011
+69% +$162K

Similar funds

UBS Group's Q3 2022 Portfolio in Review

As of Q3 2022, UBS Group held 11,885 positions worth $228B, down 6.3% from $244B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q3 2022 filing shows 1,175 new, 4,825 increased, 3,846 reduced and 1,024 closed positions. Its largest new stake was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M. The largest sale was iShares MSCI ACWI ETF, an estimated $630M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q3 2022 buy was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $324M increase.
  • UBS Group's biggest Q3 2022 reduction was iShares MSCI ACWI ETF, cutting an estimated $630M.
  • UBS Group fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $111M.
  • UBS Group's ten largest holdings make up 14% of its $228B portfolio in Q3 2022.
  • UBS Group opened 1,175 new positions and closed 1,024 in Q3 2022.
  • UBS Group's portfolio value fell 6.3% quarter-over-quarter to $228B.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.